Total Synthesis of “Aliskiren”: The First Renin Inhibitor in Clinical Practice for Hypertension
- 17 March 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 12 (8), 1816-1819
- https://doi.org/10.1021/ol100427v
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trialThe Lancet, 2007
- Cardiovascular Agents: Renin Inhibitors and Factor Xa InhibitorsHETEROCYCLES, 2007
- Renin InhibitionJournal of the American Society of Nephrology, 2005
- Angiotensin receptor blockers: Therapeutic targets and cardiovascular protectionBlood Pressure, 2005
- The renin-angiotensin-aldosterone system and the kidney: effects on kidney diseaseAmerican Journal Of Medicine, 2004
- Drugs targeting the renin–angiotensin–aldosterone systemNature Reviews Drug Discovery, 2002
- Interrupting the renin-angiotensin system: the role of angiotensin-converting enzyme inhibitors and angiotensin ii receptor antagonists in the treatment of hypertensionAmerican Journal of Hypertension, 1999
- The renin-angiotensin-aldosterone system: a specific target for hypertension managementAmerican Journal of Hypertension, 1999
- Clinical Pharmacology of the ACE InhibitorsDrugs, 1986
- Maintenance of blood pressure by the renin–angiotensin system in normal manNature, 1981